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Outline 
 HHS Regulatory requirements  
 Institutional responsibilities 
 Assurance applications 
 Written policies and procedures aka “SOPs”  
 
HHS Regulations  (45 CFR part 46) 
HHS will conduct or support non-exempt 
human subject research only if: 
 the institution has an OHRP-approved assurance, 
and  
 the institution has certified to HHS  
 research was reviewed and approved by IRB, and  
 the research will be subject to continuing review  
         §46.103(b) & (f) 
       
3 
Institutional Responsibilities 
Protect Human Subjects in Research  
 
 Responsibilities shared by Institutional  
 Officials, IRBs, and Investigators   
      
4 
Institutional Assurance 
 Documentation of institution’s 
commitment to comply with 
applicable regulations §46.103(b) & (f) 
5 
Institutional Assurance 
 Required when engaged in non-exempt human 
subject research 
 Principal method of compliance oversight 
6 
Institutional Assurance, cont’d. 
 Federalwide Assurance (FWA) - only option 
 Generally recognized by other federal departments & 
agencies 
 Designate only registered IRB(s) 
7 
Assurance Applications – 
Extending FWA 
 Individual Investigator Agreement  
 independent investigators 
 investigators at another institution 
 Assured institution responsible for oversight 
of research 
 
Sample agreement and guidance available at OHRP website: 
http://www.hhs.gov/ohrp/assurances/forms/unaflsup.rtf 
http://www.hhs.gov/ohrp/policy/guidanceonalternativetofwa.html  8 
Assurance Applications –  
  Relying on External IRB 
Institution responsibility 
 Written agreement  
 IRB authorization agreement  
       http://www.hhs.gov/ohrp/assurances/forms/iprotsup.rtf  
 Ensure research conducted per IRB approved plan 




Assure compliance with the: 
  
Terms of the Federalwide 
Assurance 
10 
Institutional Official’s Responsibilities (cont’d) 
 
 Determine application of FWA – to “check” or 
“not to check” the box 
Institutional Official’s Responsibilities (cont’d) 
 Set the "tone" for an institutional culture 
promoting ethical conduct of research 
 Support IRB actions & determinations  
Institutional Official’s Responsibilities (cont’d) 
 Ensure that investigators fulfill their 
responsibilities  
 Support training/education opportunities for 
staff 
 




 “Magnificent 7” required elements & operational 
procedures  
 Procedures necessary to meet other HHS 
requirements 











 Required Elements of   




Required Element 1 
   Procedures IRB will follow for conducting  
 initial review of research 
 
      §46.103(b)(4)(i) 
18 
Required Element 2 
   Procedures IRB will follow for conducting 
continuing review of research 
           
        §46.103(b)(4)(i) 
 
19 
Initial & Continuing Review 
Description of   
 Method of review 
 Reviewer system  
 Documents received and distributed for review  
 IRB review, findings, & determinations 
 Range of possible actions by IRB 
 Further review by institution  
20 
Method of Review 
 Convened IRB Meeting 
 Expedited  
 
21 
Convened IRB Meeting 
 Convened meeting (telephone, 
videoconference participation OK) 
 Quorum 
 majority of IRB members present 
 at least one non-scientist present 
 Approval by majority present 
22 
Expedited Review 
 Minor changes to previously approved research 





 Expedited Review (cont’d) 
Description of 
 Assignment of reviewers 
 IRB chair designates 
 criteria for assignment 
 IRB chair or experienced IRB member reviews 
 Documents distributed for review 
 Communication of approval action to all IRB 
members 
24 
Documents for Initial Review 
 Protocol summary and/or full protocol 
 Proposed informed consent document 
 Relevant HHS application or proposal  
 Recruitment and data collection materials  
 Multi-center trials (HHS supported) 
 complete approved protocol and informed consent 
document 
25 
Documents for Continuing Review 
 Protocol summary and/or full protocol,  
 include modifications previously approved 
 Current informed consent document 
 Status report: 
 number of subjects accrued 
 summary of unanticipated problems, available AE 
information, withdrawal of subjects, & complaints 
 literature summary, amendments, & modifications since 
last review 
 relevant multi-center trial reports  
 All other documents available 26 
IRB Review, Findings, & 
Determinations 
Description of process: 
 Criteria for approval under §46.111 & 
applicable subparts 
 Informed consent considerations 
 basic & additional elements §46.116(a & b)  
 altering or waiving §46.116(c or d), §46.408(c), & 
§46.101(i)  
 waiving written documentation §46.117(c)   
27 
Range of Possible IRB Actions 
Description of action: 
 Approve research  
 Require modifications in order to secure approval 
 Disapprove research (convened IRB only) 
 Suspend or terminate previously approved research 
28 
Documentation of IRB Review Process 
 OHRP recommends institutions have written 
procedures for documenting IRB findings, 
determinations, actions, and other IRB 
requirements. 
29 
Further Review by Institution 
 Who is responsible for further review 
 institutional committees, e.g., COI, Privacy Board, 
Radiation, Biosafety 
 other 
 Institutional policies relevant to review 
 Actions that may be taken by institution 
 institution may not override IRB disapproval 
30 
Required Element 3 
Procedures the IRB will follow for reporting 
its findings and actions to the investigator 
and the institution   
      §46.103(b)(4)(i)  
    
31 
Reporting IRB Actions 
To investigator 
 Written communication 
 Request for modifications or clarifications 
 Reviewing and acting upon investigator’s 
response  
32 
Reporting IRB Actions (cont’d) 
To institution 
 Written communication 
 Which institutional official(s) notified  
 How notification accomplished   
 
33 
Required Elements 4 
   Procedures the IRB will follow for determining 
which projects require review more often than 
annually 
            §46.103(b)(4)(ii)  
34 
Determining Frequency of IRB Review 
 Specific criteria used to make these 
determinations  
 Document approval period   
35 
Required Elements 5 
   Procedures the IRB will follow for determining 
which projects need verification from sources other 
than the investigator that no material changes have 
occurred since previous IRB review 
         §46.103(b)(4)(ii)  
36 
Verifying No Changes Since IRB Review   
Specific criteria, e.g.,   
 Random selection of projects 
 Complexity of project 
 History or concerns re: investigator compliance  
     
37 
Required Element 6  
   Procedures for ensuring prompt reporting to the IRB of 
proposed changes in a research activity and ensuring 
that such changes in approved research may not be 
initiated without IRB review and approval except when 
necessary to eliminate apparent immediate hazards to 
the subject 
          §46.103(b)(4)(iii) 
38 
Ensuring Protocol Changes  
Made in Accordance with Regs  
 Steps to ensure compliance, e.g.,  
 training programs for investigator, 
 specific directives included in approval letters to 
investigators, 
 random or targeted audits of research  
 Exception - eliminate apparent immediate hazards 
to subjects 
39 
Required Element 7  
   Procedures for ensuring prompt reporting to the 
IRB, appropriate institutional officials, the 
Department or Agency head, and OHRP of any 
 unanticipated problems involving risks to subjects or 
others 
 any serious or continuing noncompliance 
 any suspension or termination of IRB approval 




 Related or possibly related 
 Suggests greater risk of harm 
 
Reviewing and Reporting Unanticipated Problems 
And Adverse Events: 
http://www.hhs.gov/ohrp/policy/advevntguid.html  
41 
Most Adverse Events are not  
Unanticipated Problems 









 Who is responsible for prompt reporting 
  to whom/which office(s) or official(s) 
 Time frames for accomplishing reporting 
requirement  
 Range of possible actions taken by the IRB in 
response to reports 
Reporting Incidents to OHRP: 
http://www.hhs.gov/ohrp/policy/incidreport_ohrp.html  
 43 
Key Points -Required Elements  
of Written IRB Procedures 
 Institutions must have written procedures  
comprised of the seven required elements 
 Include step-by-step operational details that are 
user friendly and effective 
 Implement throughout the organization 
 OHRP guidance is available 
 44 
 











Subparts B, C, and D 
 Categories of permissible research 
 Research not otherwise approvable 
(Secretarial panel process) 
 Additional criteria for IRB approval  
 Special requirements for informed consent, 
parental permission, and assent  
 47 
Informed Consent Process & Documentation 
 Facilitate informed consent  
 “Long” and “short-form” consent options and 
considerations 
 Non-English speaking subjects 
 Methods for ensuring use of proper informed 
consent document  
 Who may be/must be involved in consent process 
Determining Applicability and Exemptions 
Considerations: 
 Institutional locus (e.g., IRB office) 
 Institutional person – someone with good 
foundation of human subjects’ protection 
regulations  
 Mechanism for ensuring no changes in research 
49 








Training and education program considerations  
for IRB members, investigators, & staff 
 Who 




Other Issues for Possible Inclusion  
 Important definitions 
 Preparing for review/meeting 
 IRB member selection & retention 
 IRB meeting attendance 
 IRB member responsibilities 
 Research with vulnerable populations 
52 
Other Issues for Possible Inclusion (cont’d) 
 Relying on an external IRB 
 Serving as IRB for other institutions 
 Managing allegations of non-compliance  
 Minimizing coercion and undue influence 
 Other relevant authorities 
 
53 
Key Points - Additional IRB Written   
Policies and Procedures 
 Many institutions develop comprehensive 
procedures that go beyond what is required 
 Provide helpful resource for all involved in human 
subject research 
 Establish institutional expectations   
54 
OHRP Contact Information  
 Website:  www.hhs.gov/ohrp   
 Email:  OHRP@HHS.GOV    
 Toll-free phone #:  1-866-447-4777  
 Main phone #:  240-453-6900 
 Join Listserv:  
  http://www.hhs.gov/ohrp/newsroom  
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